International Vegetative State and Consciousness Science Institute, Hangzhou Normal University
Hangzhou, Zhejiang, 3100036, China
NCT Number: NCT04164680
Recently introduced hybrid PET/MR scanners provide the opportunity to measure simultaneously, and in direct spatial correspondence, both metabolic demand and functional activity of the brain, hence capturing complementary information on the brain's physiological state. Here we exploited PET/MR simultaneous imaging to explore the relationship between the metabolic information provided by resting-state fluorodeoxyglucose-PET (FDG-PET) and fMRI (rs-fMRI) in patients with disorders of consciousness.
Looking for future studies?
Notify Me16 year–80 year
All sexes
Observational
Hangzhou, Zhejiang, 3100036, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
fludeoxyglucose (FDG-)PET/MR imaging
Time frame: Within 7 days
Use resting-state fMRI to test the functional connectivity
Time frame: Within 7 days
UseFDG-PET to test the metabolism.
Hangzhou Normal University
Other
Relationship Between Simultaneously Acquired Resting-state Regional Cerebral Glucose Metabolism and Functional MRI in DOC: a PET/MR Hybrid Scanner Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05536921
Brain Damage, Chronic, Brain Diseases
Częstochowa, Poland
View Trial DetailsNCT04921683
Anoxia, Brain, Brain Damage, Chronic
Pomona, California, United States
View Trial DetailsNCT04471753
Brain Damage, Chronic, Brain Diseases
Hangzhou, Zhejiang, China
View Trial DetailsNCT04139239
Brain Damage, Chronic, Brain Diseases
Hangzhou, Zhejiang, China
View Trial Details